Emergent BioSolutions (EBS) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.59 --0%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
GNLN, USDP, AFIB, More
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
GNLN, USDP, AFIB, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $101.5 million versus the consensus estimate of $111.2 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Greenlane Holdings Inc. (GNLN) reported Q2 result
- Paramount Global (PARA) Tops Q2 EPS by 175c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
